MR up +3.40% percent Today $MR High is at 31.09 an
Post# of 23
Posted On: 11/10/2014 2:41:24 PM
MR up +3.40% percent Today $MR High is at 31.09 and the Low 29.75 with current volume of 567,202.
Recent News posted below.
Mindray Medical International Limited MR other info.
http://investorshangout.com/Mindray-Medical-I...-MR-51863/
MR Mindray Medical International Limited Recent Headline News
The Zacks Analyst Blog Highlights: Alibaba Group Holding, Mindray Medical International, Changyou.com, NetEase and China Mobile
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Alibaba Group Holding Ltd. (NYSE:BABA-Free Report), Mindray Medical International Ltd. (NYSE:MR-Free Report), Changyou.com Ltd. (Nasdaq:CYOU-Free Report), NetEase, Inc. (Nasdaq:NTES-Free Report) and China Mobile Ltd. (NYSE:CHL-Free Report).
CYOU: 23.53 (+1.12), MR: 30.73 (+0.74), BABA: 118.07 (+3.51)
China Stock Roundup: Alibaba Misses, Mindray Meets Estimates - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Nov 06, 9:41AM CST
Markets experienced another largely positive week, indicating that the economy is responding positively to the government's reform agenda.
WB: 19.62 (+0.59), NTES: 92.83 (+1.03), CHL: 62.75 (+0.59), CYOU: 23.53 (+1.12), MR: 30.73 (+0.74), BABA: 118.07 (+3.51)
Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 32.80 (+0.67), FLDM: 29.00 (+0.10), ANGO: 16.92 (-0.03), MR: 30.73 (+0.74)
Mindray Medical International's (MR) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 12:13PM CST
MR: 30.73 (+0.74)
Mindray Medical International Limited (MR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 6:55AM CST
MR: 30.73 (+0.74)
Mindray Medical beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:02PM CST
MR: 30.73 (+0.74)
Mindray Announces Third Quarter 2014 Financial Results
PR Newswire - Mon Nov 03, 4:00PM CST
Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2014.
MR: 30.73 (+0.74)
7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST
KND: 20.96 (+0.28), VIVO: 17.16 (+0.31), PETS: 13.54 (+0.26), PFE: 30.26 (+0.34), GSK: 45.17 (+0.26), MR: 30.73 (+0.74), SEM: 13.67 (+0.05), PDLI: 7.83 (-0.15), SNN: 33.29 (+0.08), AZN: 73.36 (+0.48), MRK: 58.84 (-0.50), STJ: 65.62 (+0.86), TRIB: 17.78 (+0.35), ABBV: 63.66 (+2.16), THRX: 13.38 (-0.89), SNY: 46.31 (+0.62)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST
RKT: 56.05 (+0.62), HLF: 38.15 (+0.65), EGAN: 5.29 (-0.02), CUTR: 10.60 (-0.09), DXPE: 67.15 (+1.52), AEIS: 20.56 (+0.15), NOR: 4.05 (-0.13), KBR: 19.16 (-0.12), SGY: 22.06 (-1.70), RTEC: 9.18 (+0.08), PKT: 7.27 (+0.08), OGS: 39.00 (-0.33), BKH: 56.43 (-0.23), KAMN: 41.37 (+0.12), EOX: 3.03 (-0.08), MR: 30.73 (+0.74), RKUS: 12.53 (-0.12), LCI: 51.41 (+1.24), NBIX: 18.74 (+0.16), PQ: 3.92 (-0.09), RBC: 70.51 (-0.90), CHGG: 6.95 (+0.23), AIG: 54.24 (+0.21), MRO: 33.29 (-1.10), GRT: 13.88 (+0.06), EPAM: 46.62 (-0.33), CKP: 12.89 (+0.23), SBRA: 28.46 (+0.19), MDU: 26.01 (-0.35), NTRI: 17.92 (-0.07), ELNK: 4.31 (+0.07), EQC: 26.20 (-0.02), CVD: 100.69 (+0.17), IART: 47.46 (+0.41), FN: 17.69 (+0.28), APL: 34.26 (-0.21), BDE: 8.39 (-0.06), AGU: 97.67 (-0.75), PLOW: 22.97 (+0.94), REG: 61.98 (+0.44), QLYS: 35.79 (+1.31), GALE: 1.90 (-0.05), ANV: 1.07 (+0.02), ININ: 48.29 (+0.04), FTR: 6.46 (+0.02), GTY: 18.78 (+0.14), MCEP: 17.67 (-0.49), CYH: 48.30 (+0.49), SKH: 7.08 (+0.20), ACXM: 19.04 (-0.02), PL: 69.76 (+0.05), RLD: 11.50 (-0.08), CXW: 36.66 (+0.36), SALE: 14.97 (+0.62), ENH: 57.42 (-0.78), CRK: 11.39 (-0.04), AMTG: 16.24 (-0.16), OTTR: 31.00 (+0.06), NLS: 14.66 (-0.28)
Mindray Medical to Exhibit New Products at Upcoming Medical Equipment Fairs
PR Newswire - Wed Oct 15, 7:00AM CDT
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it will exhibit its latest products at three of the world's largest medical equipment events, including the 72th China International Medical Equipment Fair ("CMEF"
in China, MEDICA 2014 in Germany, and the 100th Annual Meeting of Radiological Society of North America ("RSNA 2014" in the United States.
MR: 30.73 (+0.74)
Mindray to Report Third Quarter 2014 Financial Results on Nov 3, 2014
PR Newswire - Tue Oct 14, 7:00AM CDT
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the third quarter ended Sept 30, 2014 after the U.S. market closes on Nov 3, 2014. Mindray's management will hold an earnings conference call at 8:00 AM on Nov 4, 2014 U.S. Eastern Time (9:00 PM on Nov 4, 2014 Beijing/Hong Kong Time).
MR: 30.73 (+0.74)
Analysts View on Health Care Equipment and Supplies Equities - Mindray Medical Intl., Alere, Align Technology, Antares Pharma, and Unilife
PR Newswire - Wed Sep 24, 7:50AM CDT
The US markets on Tuesday, September 23, 2014, ended on a negative note as the Dow Jones Industrial Average finished at 17,055.87, down 0.68% and the NASDAQ Composite closed at 4,508.69, down 0.42%. The S&P 500 finished the session 0.58% lower at 1,982.77. During the trading session, all the ten sectors finished on a lower note. The S&P 500 Health Care Sector Index ended the day at 742.96, down 0.58%, whereas the index has advanced 6.07% in the previous three months. Investor-Edge has initiated coverage on the following equities: Mindray Medical International Ltd. (NYSE: MR), Alere Inc. (NYSE: ALR), Align Technology Inc. (NASDAQ: ALGN), Antares Pharma Inc. (NASDAQ: ATRS), and Unilife Corporation (NASDAQ: UNIS). Free research on these five companies can be accessed at:
UNIS: 3.62 (+0.04), ALGN: 52.18 (-0.21), ALR: 39.49 (+0.12), MR: 30.73 (+0.74), ATRS: 2.23 (+0.06)
China's Near-Term Fears Obscure Long-Term View: 3 Stocks to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 9:07AM CDT
Recent economic data in China and related events do not suggest a bullish trend, though IHS predicts China's nominal gross domestic product to reach $28.25 trillion in 2024.
YGE: 2.79 (+0.02), JD: 26.43 (+1.69), MR: 30.73 (+0.74)
Quality Exams at Your Fingertips
PR Newswire Europe - Wed Sep 17, 5:12AM CDT
-- Mindray Releases New Generation DC-70 Ultrasound System
MR: 30.74 (+0.75)
Mindray Medical Down to Strong Sell on Weak Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 12:30PM CDT
For 2014, three estimates moved down in the past 30 days for Mindray Medical International Limited (MR), with no upward revision, sinking the Zacks Consensus Estimate by 7.7% to $1.81 per share.
ATEC: 1.44 (+0.05), RTIX: 5.01 (-0.08), MR: 30.74 (+0.75), ERB: 2.79 (-0.33)
Hematology Instruments and Reagents - 2014 Global Strategic Business Report
M2 - Thu Aug 21, 2:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fz4292/hematology) has announced the addition of the "Hematology Instruments and Reagents - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Hematology Instruments and Reagents in US$ Thousands by the following Product Segments: - Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, & Hematology Vials) - Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, & Hematology Stains). The report profiles 78 companies including many key and niche players such as: - Abbott Diagnostics, Inc. - Beckman Coulter, Inc. - Bio-Rad Laboratories, Inc. - Drucker Diagnostics - Horiba Ltd. - Instrumentation Laboratory, Inc. - Mindray Medical International Limited - Roche Diagnostics - Siemens Healthcare - Sigma-Aldrich Corporation - Stago - Sysmex Corporation - Sysmex America, Inc. - Tcoag Ireland Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Industry Overview & Trends 3. Competitive Scenario 4. Key Product Segments 5. Blood The All Pervasive Connective Tissue 6. Hematology The Core Idea 8. Blood Testing Developments A Historic Review 9. Product Introductions/Innovations 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 78 (including Divisions/Subsidiaries 111) - The United States (40) - Japan (10) - Europe (37) - France (7) - Germany (
- The United Kingdom (5) - Italy (3) - Spain (2) - Rest of Europe (12) - Asia-Pacific (Excluding Japan) (22) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/fz4292/hematology
SIAL: 135.82 (+0.48), MR: 30.74 (+0.75)
The Zacks Analyst Blog Highlights: ReneSola, eLong, China Unicom Hong Kong, Mindray Medical International and Bitauto Holdings
PR Newswire - Fri Aug 15, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the ReneSola Ltd (NYSE:SOL-Free Report), eLong Inc. (Nasdaq:LONG-Free Report), China Unicom Hong Kong Limited (NYSE:CHU-Free Report), Mindray Medical International Limited (NYSE:MR-Free Report) and Bitauto Holdings Limited (NYSE:BITA-Free Report).
CHU: 14.42 (-0.31), LONG: 18.40 (-0.10), MR: 30.74 (+0.75)
MediPoint: Diagnostic X-ray Imaging - APAC Analysis and Market Forecasts 2014: GE Healthcare, Siemens, and Philips Account for Over 40% of Market Share
M2 - Fri Aug 15, 4:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3xzgjs/medipoint) has announced the addition of the "MediPoint: Diagnostic X-ray Imaging - APAC Analysis and Market Forecasts" company profile to their offering. According to estimates, GE Healthcare, Siemens, and Philips together accounted for over 40% of the market share within the APAC diagnostic X-ray imaging market in 2012. This is mainly attributed to these companies' geographical and product portfolio diversity. They are all a part of large conglomerates with robust financial resources to invest in inorganic growth and R&D; therefore, these players have a significant market share. Scope - An overview of Diagnostic X-Ray Imaging, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC Diagnostic X-Ray Imaging market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Diagnostic X-Ray Imaging. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Diagnostic X-Ray Imaging sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs Analysis 5 Market Opportunity Analysis 6 Market Drivers and Barriers 7 Competitive Assessment 8 Pipeline Assessment 9 Current and Future Players 10 Market Outlook 11 Appendix Companies Mentioned - Agfa Healthcare - Allengers Medical Systems - Canon - Carestream Health - China Resources Wandong Medical Equipment - Fujifilm Holdings - GE Healthcare - General Medical Merate - Hitachi Medical - Konica Minolta - Mindray Medical International - Neusoft Medical - Philips Healthcare - Samsung Electronics - Shimadzu Corporation - Siemens Healthcare - Swissray International - Toshiba Medical Systems For more information visit http://www.researchandmarkets.com/research/3xzgjs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MR: 30.74 (+0.75)
China Stock Roundup: ReneSola, eLong Reverse Losses, China Unicom 1H14 Net Income Surges - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Aug 14, 1:06PM CDT
Stocks had a mixed week after posting substantial gains on Monday.
SOL: 2.25 (-0.02), CHU: 14.42 (-0.31), LONG: 18.40 (-0.10), TSL: 10.24 (-0.05), MR: 30.74 (+0.75), BITA: 82.07 (+2.76)
Recent News posted below.
Mindray Medical International Limited MR other info.
http://investorshangout.com/Mindray-Medical-I...-MR-51863/
MR Mindray Medical International Limited Recent Headline News
The Zacks Analyst Blog Highlights: Alibaba Group Holding, Mindray Medical International, Changyou.com, NetEase and China Mobile
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Alibaba Group Holding Ltd. (NYSE:BABA-Free Report), Mindray Medical International Ltd. (NYSE:MR-Free Report), Changyou.com Ltd. (Nasdaq:CYOU-Free Report), NetEase, Inc. (Nasdaq:NTES-Free Report) and China Mobile Ltd. (NYSE:CHL-Free Report).
CYOU: 23.53 (+1.12), MR: 30.73 (+0.74), BABA: 118.07 (+3.51)
China Stock Roundup: Alibaba Misses, Mindray Meets Estimates - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Nov 06, 9:41AM CST
Markets experienced another largely positive week, indicating that the economy is responding positively to the government's reform agenda.
WB: 19.62 (+0.59), NTES: 92.83 (+1.03), CHL: 62.75 (+0.59), CYOU: 23.53 (+1.12), MR: 30.73 (+0.74), BABA: 118.07 (+3.51)
Mindray Medical Q3 Earnings in Line, 2014 View Lowered - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 2:07PM CST
Mindray Medical International Limited (MR) slashed its 2014 financial guidance in the face of increasing uncertainties in currency and other macro developments that could impact its performance in certain key markets.
ABMD: 32.80 (+0.67), FLDM: 29.00 (+0.10), ANGO: 16.92 (-0.03), MR: 30.73 (+0.74)
Mindray Medical International's (MR) Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 12:13PM CST
MR: 30.73 (+0.74)
Mindray Medical International Limited (MR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 6:55AM CST
MR: 30.73 (+0.74)
Mindray Medical beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:02PM CST
MR: 30.73 (+0.74)
Mindray Announces Third Quarter 2014 Financial Results
PR Newswire - Mon Nov 03, 4:00PM CST
Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2014.
MR: 30.73 (+0.74)
7 Old Dividend Dogs Of Healthcare Aim At 11% To 30.5% October Upsides
Fredrik Arnold - at Seeking Alpha - Mon Nov 03, 11:21AM CST
KND: 20.96 (+0.28), VIVO: 17.16 (+0.31), PETS: 13.54 (+0.26), PFE: 30.26 (+0.34), GSK: 45.17 (+0.26), MR: 30.73 (+0.74), SEM: 13.67 (+0.05), PDLI: 7.83 (-0.15), SNN: 33.29 (+0.08), AZN: 73.36 (+0.48), MRK: 58.84 (-0.50), STJ: 65.62 (+0.86), TRIB: 17.78 (+0.35), ABBV: 63.66 (+2.16), THRX: 13.38 (-0.89), SNY: 46.31 (+0.62)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST
RKT: 56.05 (+0.62), HLF: 38.15 (+0.65), EGAN: 5.29 (-0.02), CUTR: 10.60 (-0.09), DXPE: 67.15 (+1.52), AEIS: 20.56 (+0.15), NOR: 4.05 (-0.13), KBR: 19.16 (-0.12), SGY: 22.06 (-1.70), RTEC: 9.18 (+0.08), PKT: 7.27 (+0.08), OGS: 39.00 (-0.33), BKH: 56.43 (-0.23), KAMN: 41.37 (+0.12), EOX: 3.03 (-0.08), MR: 30.73 (+0.74), RKUS: 12.53 (-0.12), LCI: 51.41 (+1.24), NBIX: 18.74 (+0.16), PQ: 3.92 (-0.09), RBC: 70.51 (-0.90), CHGG: 6.95 (+0.23), AIG: 54.24 (+0.21), MRO: 33.29 (-1.10), GRT: 13.88 (+0.06), EPAM: 46.62 (-0.33), CKP: 12.89 (+0.23), SBRA: 28.46 (+0.19), MDU: 26.01 (-0.35), NTRI: 17.92 (-0.07), ELNK: 4.31 (+0.07), EQC: 26.20 (-0.02), CVD: 100.69 (+0.17), IART: 47.46 (+0.41), FN: 17.69 (+0.28), APL: 34.26 (-0.21), BDE: 8.39 (-0.06), AGU: 97.67 (-0.75), PLOW: 22.97 (+0.94), REG: 61.98 (+0.44), QLYS: 35.79 (+1.31), GALE: 1.90 (-0.05), ANV: 1.07 (+0.02), ININ: 48.29 (+0.04), FTR: 6.46 (+0.02), GTY: 18.78 (+0.14), MCEP: 17.67 (-0.49), CYH: 48.30 (+0.49), SKH: 7.08 (+0.20), ACXM: 19.04 (-0.02), PL: 69.76 (+0.05), RLD: 11.50 (-0.08), CXW: 36.66 (+0.36), SALE: 14.97 (+0.62), ENH: 57.42 (-0.78), CRK: 11.39 (-0.04), AMTG: 16.24 (-0.16), OTTR: 31.00 (+0.06), NLS: 14.66 (-0.28)
Mindray Medical to Exhibit New Products at Upcoming Medical Equipment Fairs
PR Newswire - Wed Oct 15, 7:00AM CDT
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it will exhibit its latest products at three of the world's largest medical equipment events, including the 72th China International Medical Equipment Fair ("CMEF"
in China, MEDICA 2014 in Germany, and the 100th Annual Meeting of Radiological Society of North America ("RSNA 2014" in the United States. MR: 30.73 (+0.74)
Mindray to Report Third Quarter 2014 Financial Results on Nov 3, 2014
PR Newswire - Tue Oct 14, 7:00AM CDT
Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the third quarter ended Sept 30, 2014 after the U.S. market closes on Nov 3, 2014. Mindray's management will hold an earnings conference call at 8:00 AM on Nov 4, 2014 U.S. Eastern Time (9:00 PM on Nov 4, 2014 Beijing/Hong Kong Time).
MR: 30.73 (+0.74)
Analysts View on Health Care Equipment and Supplies Equities - Mindray Medical Intl., Alere, Align Technology, Antares Pharma, and Unilife
PR Newswire - Wed Sep 24, 7:50AM CDT
The US markets on Tuesday, September 23, 2014, ended on a negative note as the Dow Jones Industrial Average finished at 17,055.87, down 0.68% and the NASDAQ Composite closed at 4,508.69, down 0.42%. The S&P 500 finished the session 0.58% lower at 1,982.77. During the trading session, all the ten sectors finished on a lower note. The S&P 500 Health Care Sector Index ended the day at 742.96, down 0.58%, whereas the index has advanced 6.07% in the previous three months. Investor-Edge has initiated coverage on the following equities: Mindray Medical International Ltd. (NYSE: MR), Alere Inc. (NYSE: ALR), Align Technology Inc. (NASDAQ: ALGN), Antares Pharma Inc. (NASDAQ: ATRS), and Unilife Corporation (NASDAQ: UNIS). Free research on these five companies can be accessed at:
UNIS: 3.62 (+0.04), ALGN: 52.18 (-0.21), ALR: 39.49 (+0.12), MR: 30.73 (+0.74), ATRS: 2.23 (+0.06)
China's Near-Term Fears Obscure Long-Term View: 3 Stocks to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 9:07AM CDT
Recent economic data in China and related events do not suggest a bullish trend, though IHS predicts China's nominal gross domestic product to reach $28.25 trillion in 2024.
YGE: 2.79 (+0.02), JD: 26.43 (+1.69), MR: 30.73 (+0.74)
Quality Exams at Your Fingertips
PR Newswire Europe - Wed Sep 17, 5:12AM CDT
-- Mindray Releases New Generation DC-70 Ultrasound System
MR: 30.74 (+0.75)
Mindray Medical Down to Strong Sell on Weak Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 09, 12:30PM CDT
For 2014, three estimates moved down in the past 30 days for Mindray Medical International Limited (MR), with no upward revision, sinking the Zacks Consensus Estimate by 7.7% to $1.81 per share.
ATEC: 1.44 (+0.05), RTIX: 5.01 (-0.08), MR: 30.74 (+0.75), ERB: 2.79 (-0.33)
Hematology Instruments and Reagents - 2014 Global Strategic Business Report
M2 - Thu Aug 21, 2:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/fz4292/hematology) has announced the addition of the "Hematology Instruments and Reagents - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Hematology Instruments and Reagents in US$ Thousands by the following Product Segments: - Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, & Hematology Vials) - Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, & Hematology Stains). The report profiles 78 companies including many key and niche players such as: - Abbott Diagnostics, Inc. - Beckman Coulter, Inc. - Bio-Rad Laboratories, Inc. - Drucker Diagnostics - Horiba Ltd. - Instrumentation Laboratory, Inc. - Mindray Medical International Limited - Roche Diagnostics - Siemens Healthcare - Sigma-Aldrich Corporation - Stago - Sysmex Corporation - Sysmex America, Inc. - Tcoag Ireland Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Outlook 2. Industry Overview & Trends 3. Competitive Scenario 4. Key Product Segments 5. Blood The All Pervasive Connective Tissue 6. Hematology The Core Idea 8. Blood Testing Developments A Historic Review 9. Product Introductions/Innovations 10. Recent Industry Activity 11. Focus On Select Players 12. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 78 (including Divisions/Subsidiaries 111) - The United States (40) - Japan (10) - Europe (37) - France (7) - Germany (
- The United Kingdom (5) - Italy (3) - Spain (2) - Rest of Europe (12) - Asia-Pacific (Excluding Japan) (22) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/fz4292/hematology SIAL: 135.82 (+0.48), MR: 30.74 (+0.75)
The Zacks Analyst Blog Highlights: ReneSola, eLong, China Unicom Hong Kong, Mindray Medical International and Bitauto Holdings
PR Newswire - Fri Aug 15, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the ReneSola Ltd (NYSE:SOL-Free Report), eLong Inc. (Nasdaq:LONG-Free Report), China Unicom Hong Kong Limited (NYSE:CHU-Free Report), Mindray Medical International Limited (NYSE:MR-Free Report) and Bitauto Holdings Limited (NYSE:BITA-Free Report).
CHU: 14.42 (-0.31), LONG: 18.40 (-0.10), MR: 30.74 (+0.75)
MediPoint: Diagnostic X-ray Imaging - APAC Analysis and Market Forecasts 2014: GE Healthcare, Siemens, and Philips Account for Over 40% of Market Share
M2 - Fri Aug 15, 4:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3xzgjs/medipoint) has announced the addition of the "MediPoint: Diagnostic X-ray Imaging - APAC Analysis and Market Forecasts" company profile to their offering. According to estimates, GE Healthcare, Siemens, and Philips together accounted for over 40% of the market share within the APAC diagnostic X-ray imaging market in 2012. This is mainly attributed to these companies' geographical and product portfolio diversity. They are all a part of large conglomerates with robust financial resources to invest in inorganic growth and R&D; therefore, these players have a significant market share. Scope - An overview of Diagnostic X-Ray Imaging, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC Diagnostic X-Ray Imaging market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Diagnostic X-Ray Imaging. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Diagnostic X-Ray Imaging sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs Analysis 5 Market Opportunity Analysis 6 Market Drivers and Barriers 7 Competitive Assessment 8 Pipeline Assessment 9 Current and Future Players 10 Market Outlook 11 Appendix Companies Mentioned - Agfa Healthcare - Allengers Medical Systems - Canon - Carestream Health - China Resources Wandong Medical Equipment - Fujifilm Holdings - GE Healthcare - General Medical Merate - Hitachi Medical - Konica Minolta - Mindray Medical International - Neusoft Medical - Philips Healthcare - Samsung Electronics - Shimadzu Corporation - Siemens Healthcare - Swissray International - Toshiba Medical Systems For more information visit http://www.researchandmarkets.com/research/3xzgjs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MR: 30.74 (+0.75)
China Stock Roundup: ReneSola, eLong Reverse Losses, China Unicom 1H14 Net Income Surges - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Aug 14, 1:06PM CDT
Stocks had a mixed week after posting substantial gains on Monday.
SOL: 2.25 (-0.02), CHU: 14.42 (-0.31), LONG: 18.40 (-0.10), TSL: 10.24 (-0.05), MR: 30.74 (+0.75), BITA: 82.07 (+2.76)
(0)
(0)Montage Resources Corporation (MR) Stock Research Links
Scroll down for more posts ▼